NDC 42858-721 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

Dextroamphetamine Saccharate 1.25 mg/1; Amphetamine Aspartate Monohydrate 1.25 mg/1; Dextroamphetamine Sulfate 1.25 mg/1; Amphetamine Sulfate 1.25 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC42858-721

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Labeler
Rhodes Pharmaceuticals LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213111
Marketed since
September 9, 2021
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
42858-721-01100 TABLET in 1 BOTTLE (42858-721-01)Sep 9, 2021

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products